The drug repurposing approach CUSP9v3 has a strong antineoplastic activity against medulloblastoma in vitro
Christopher Loehmann (Ulm), Annika Hajosch (Ulm), Richard Eric Kast (Burlington/ US), Michal Hlavac (Ulm), Mike-Andrew Westhoff (Ulm), Markus David Siegelin (New York, NY/ US), Marc-Eric Halatsch (Winterthur/ CH), Christian Rainer Wirtz (Ulm), Georg Karpel-Massler (Ulm)